BIOM-35. Multi Analyte Assay for Non-Invasive Diagnosis of Brain Tumors (original) (raw)

Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors

International Journal of Molecular Sciences, 2021

Advances on Liquid Biopsy Analysis for Glioma Diagnosis

Biomedicines

Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors

Dolores López-terrada

Archives of Pathology & Laboratory Medicine

View PDFchevron_right

Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients

Elisa Izquierdo

Neuro-Oncology Advances, 2021

View PDFchevron_right

Liquid biopsy in gliomas: A RANO review and proposals for clinical applications

Martin Van Den Bent

Neuro-oncology, 2022

View PDFchevron_right

Methods of glioma sample processing for molecular diagnosis for the glioma tissue bank project

Ying Mao

Biopreservation and biobanking, 2015

View PDFchevron_right

Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid

Fran Martínez-ricarte

Clinical cancer research : an official journal of the American Association for Cancer Research, 2018

View PDFchevron_right

Detection of Tumor-derived DNA in Cerebrospinal Fluid

Suely Marie

Journal of Neuropathology & Experimental Neurology, 1994

View PDFchevron_right

Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics

Sara Castaner

Frontiers in Neurology, 2022

View PDFchevron_right

Rapid Spectroscopic Liquid Biopsy for the Universal Detection of Brain Tumours

Christopher Rinaldi

Cancers, 2021

View PDFchevron_right

Indication of intraoperative immunohistochemistry for accurate pathological diagnosis of brain tumors

Manabu Natsumeda

Brain Tumor Pathology, 2011

View PDFchevron_right

Assessment of the Efficacy of Circulating Tumor Cells by Liquid Biopsy in the Diagnosis and Prediction of Tumor Behavior of Gliomas: A Systematic Review

jano roy s g

Curēus, 2024

View PDFchevron_right

Challenges in the Histopathologic Diagnosis of Brain Tumors: An Institutional Experience in a Series of Cases

Ananthan Raghothaman

Journal of Health and Allied Sciences NU, 2022

View PDFchevron_right

Molecular and Circulating Biomarkers in Patients with Glioblastoma

Sanae Bennis

International Journal of Molecular Sciences

View PDFchevron_right

Assisting the neurologist in diagnosis of CNS malignancies - Current Possibilities and Limits of Cerebrospinal Fluid Cytology and Immunocytochemistry

Ondrej Sobek

Brain and Behavior, 2017

View PDFchevron_right

Liquid Biopsy in Diagnosis and Prognosis of High-Grade Gliomas; State-of-the-Art and Literature Review

Gianluca Scalia

Life, 2022

View PDFchevron_right

Circulating biomarkers in patients with glioblastoma

Chamindie Punyadeera

British Journal of Cancer, 2019

View PDFchevron_right

Pitfalls in the diagnosis of brain tumours

Cláudia Leite

The Lancet Neurology, 2006

View PDFchevron_right

Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors

Mark Routbort

Journal of neuropathology and experimental neurology, 2017

View PDFchevron_right

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas

Martin Van Den Bent

Archives of Pathology & Laboratory Medicine, 2022

View PDFchevron_right

Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors

Santosh Kesari

CNS Oncology

View PDFchevron_right

An Overview of Brain Tumor

Manimekalai pichaivel

Brain Tumors [Working Title], 2022

View PDFchevron_right

Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancer

Loren Christie

Neuro-Oncology Advances, 2022

View PDFchevron_right

The Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade 4 Astrocytoma

Saleh S Baeesa

Cureus

View PDFchevron_right

Audit of histomorphology and immunohistochemistry of the brain tumors: Revisited in context to the WHO 2016 molecular classification

Tanushri Mukherjee

View PDFchevron_right

Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors

James Haberberger

Frontiers in Neurology, 2020

View PDFchevron_right

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

Santiago Ramon Y Cajal

Nature Communications, 2015

View PDFchevron_right

Current Challenges and Future Directions in Screening for Brain Tumours

Joao Santiago

Acta medica portuguesa

View PDFchevron_right

BIOM-35. Multi Analyte Assay for Non-Invasive Diagnosis of Brain Tumors (original) (raw)

Related papers